MedTrace Logo

Comparative PK PD Study in PAH Patients (Fox vs. I-Neb)

NCT02032836 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 27

Last updated 2018-09-26

No results posted yet for this study

Summary

Administration of iloprost aerosol comparing two nebulizers: FOX and I-Neb

Conditions

Interventions

DRUG

lloprost(Ventavis,BAYQ6252, 20 µg/mL)

20 µg/mL iloprost nebulizer solution, inhaled with FOX nebulizer

DRUG

lloprost(Ventavis,BAYQ6252, 10 µg/mL)

10 µg/mL iloprost nebulizer solution, inhaled with I-Neb nebulizer

Sponsors & Collaborators

Principal Investigators

  • Bayer Study Director · Bayer

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-03-10
Primary Completion
2015-01-07
Completion
2017-09-29

Countries

  • Austria
  • Germany

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02032836 on ClinicalTrials.gov